Bold and Italic Inside Tables
Bold cells in a table—mark each cell or the whole column?
✅ NormativeSettled. The requirement holds as written.📄 Page ruleCan be applied from the page alone.Read §9.6.2 in the RFC ↗
Inside a table, bold, italic and underline MUST be marked per cell, and only where the printed
glyphs of that cell are heavier, slanted or underlined. A whole column or a whole header row MUST
NOT be styled on principle. Inside an HTML table cell, bold MUST be written <strong>, italic
<em> and underline <u>.
When it applies
The same holds for strikeout and coloured text: they are properties of the glyphs in one cell, not of the role that cell plays.
Page bolds one column: Over-bolded output:
| **Doc** | Status | | **Doc** | **Status** |
| **A-1** | Filed | | **A-1** | **Filed** |
The block on the right is the error this rule exists to prevent: the page bolds a single column, and every cell came back bold.
Reading the examples. Each one pairs a source page with the output the rule expects. ✅ Sample: the rule applies. ❌ Counter-sample: it looks like it applies and does not, or a rendering got it wrong. A non-conforming output, in red, is shown only for contrast. … marks content left out of an excerpt.
Markup inside a cell
Emphasis inside a table cell is written with HTML elements, not Markdown ** and *. Strikeout inside a cell follows Struck and Replaced Values (§9.6.7).
| Printed | Rendering in a cell |
|---|---|
| Bold | <td><strong>Net sales</strong></td> |
| Italic | <td><em>P. abyssalis</em></td> |
| Bold and italic | <td><em><strong>All other plans</strong></em></td> |
| Underlined | <th><u>Rx Claim Information</u></th> |
| Styling on part of a cell | only that run: <td><em>ZRK2</em> kinase inhibitor</td> |
**…**and*…*MUST NOT be used inside a table cell.- The markup MUST cover exactly the styled run. A cell that is bold throughout wraps its whole content; a cell with one bold word wraps that word.
Header rows
A <th> cell states the cell's role, not its weight. Where every cell of the header rows is printed
in the same weight, that shared weight SHOULD NOT be repeated as <strong> in each header cell —
that styles the header row on principle. A header cell whose glyphs differ from the rest
of the header — an italic stub heading, an underlined label, one bold heading among regular ones —
MUST carry that difference.
Deciding cell by cell
- The structure — rows, columns, header tiers — is read first, blind to weight and slant.
- Styling is then taken from the glyphs of each cell, one cell at a time.
Weight differences are often subtle, so a cell is judged against its neighbours rather than on its own. Where it cannot be told whether a cell is heavier, the cell SHOULD be left unstyled: an unmarked cell loses a nuance, a wrongly marked one asserts something the page does not say.
Only the rate-value cells are bold70th
the plan-design cells beside them are not. Per cell, as printed
— though the weight difference is subtle on the page, which is part of why producers over-apply
it. The column headings are bold as a whole header, so they carry no <strong>; each is one
wrapped label.
Source page

Expected output · excerpt
| Monthly Rates For Groups Entering/Renewing | Copays Medical/ER/Inpatient/Amb | Non Par Deductible | Coinsurance | Coinsurance Maximum | UCR | Non Par Annual Maximum | 2 TIER RATES | 4 TIER RATES | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ind | Family | Ind | EC | ES | ESC | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 7/1/12 - 9/30/12 | $30 / $100 / $500 / $250 | $1,000 / $3,000 | 70% / 30% | $3,000 / $9,000 | 70th%ile | $1,000,000 | $755.26 | $2,190.26 | $755.26 | $1,397.23 | $1,812.64 | $2,265.77 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 7/1/12 - 9/30/12 | $30 / $100 / $500 / $0 | $2,000 / $6,000 | 70% / 30% | $3,000 / $9,000 | 70th%ile | $500,000 | $766.04 | $2,221.49 | $766.04 | $1,417.16 | $1,838.50 | $2,298.12 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 7/1/12 - 9/30/12 | $30 / $100 / $300 x 5 / $250 | $2,000 / $6,000 | 70% / 30% | $3,000 / $9,000 | 70th%ile | $1,000,000 | $729.06 | $2,114.36 | $729.06 | $1,348.82 | $1,749.82 | $2,187.26 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| … | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Only the three Tarnwick Capital Partners index rows are bold — per row, not blanketsingle
Their labels
are printed in mixed case and end in a superscript 1. One label wraps at the column edge and is
joined.
Source page

Expected output
| Index | 1-Quarter | YTD | 1-Year | 3-Year | 5-Year | 10-Year | 15-Year |
|---|---|---|---|---|---|---|---|
| Tarnwick Capital Partners LLC Timber Impact Investing Index1 | 0.29 | 1.12 | -0.89 | 1.21 | 2.66 | 3.28 | 3.82 |
| Tarnwick Capital Partners LLC Real Estate Impact Investing Index1 | 0.66 | 0.44 | 1.14 | 1.13 | -0.87 | 1.43 | — |
| Tarnwick Capital Partners LLC Infrastructure Impact Investing Index1 | -0.23 | -0.41 | -0.65 | 2.64 | 1.63 | 2.32 | — |
| Merevald Global Natural Resources Index | 1.09 | 13.44 | -4.63 | 10.72 | 0.13 | 2.92 | 6.18 |
| Vantage World Natural Resources Index (net) | -0.71 | 14.09 | -8.57 | 5.21 | -4.27 | 2.84 | 4.87 |
| Vantage US Natural Resources Index (net) | -2.88 | 12.69 | -14.14 | -0.39 | -6.53 | 3.72 | 5.25 |
| Vantage Emerging Markets Natural Resources Index (gross) | 1.47 | 12.20 | 11.78 | 18.52 | 2.38 | 2.02 | 8.13 |
| Solace® All Equity REIT Index | 1.79 | 19.27 | 13.01 | 5.92 | 8.88 | 16.03 | 9.41 |
| Solace® Developed Real Estate Index | 0.20 | 15.09 | 8.64 | 5.45 | 5.79 | 11.45 | 8.00 |
| Constructed Index: Harborline Global Infra/Harborline Infra&Utilities 50/50/Merevald Global Infrastructure | 5.34 | 20.15 | 12.17 | 8.78 | 5.46 | 9.86 | 9.19 |
| Beacon Global Aggregate Bond Index | 3.29 | 5.57 | 5.85 | 1.62 | 1.20 | 2.89 | 3.76 |
| Cornerstone Timberland Index | 1.51 | 3.34 | 6.51 | 6.89 | 8.83 | 9.25 | 8.70 |
ZRK2 and Pspa
abyssalis (P. abyssalis) italicised within otherwise plain cells — per run, not per cell. The phase labels printed in coloured pills are bold; the pill colour repeats what the text says and is not carried.
Source page

Expected output
| Compound Name | Mechanism of Action | Target Indication | Phase of Development | Submission Type |
|---|---|---|---|---|
| ZENTOVI® (larotanib)+ VESTOVI® (kalitrafenib)1 | ZRK2 kinase inhibitor and MEK inhibitor | ZRK2 V600E-mutant Metastatic Non-small Cell Lung Cancer | Approved (Ongoing Phase 2) | Product Enhancement |
| cerovatug vedotin (SB-08046) | Integrin beta-6-directed antibody-drug conjugate | 2L+ Metastatic Non-Small Cell Lung Cancer (mNSCLC) (SB6A LUNG-01) (Biologic) | Phase 3 | New Molecular Entity |
| belrociclib (SB-07220) | CDK4 inhibitor | 2L HR+/HER2- Metastatic Breast Cancer | Phase 3 | New Molecular Entity |
| NORFULO™ (velcitinib) | JAK3/TEC inhibitor | Vitiligo | Phase 3 | Product Enhancement |
| Marsh Fever Vaccine2 | Prophylactic vaccine - protein subunit | Marsh Fever (FAST TRACK - U.S) | Phase 3 | New Molecular Entity |
| SB-07831 | Prophylactic vaccine – protein subunit | P. abyssalis (P. abyssalis) – updated formulation | Phase 2 | New Molecular Entity |
| SB-07872 | Prophylactic vaccine – polysaccharide conjugate | Marsh Pox Infection (FAST TRACK – U.S.) | Phase 2 | New Molecular Entity |
| orenatrelvir (SB-07817) | Oral protease inhibitor (oral antiviral treatment) | Seasonal Flu Infection (FAST TRACK – U.S.) | Phase 2 | New Molecular Entity |
| danuprogab (SB-06882) | Glucagon-like peptide 1 receptor (GLP-1R) agonist | Chronic Weight Management | Phase 1 | New Molecular Entity |
One stub cell bold only, the next bold and italic — a genuine per-cell style distinction3r
The
column headings share one weight and carry no <strong>.
Source page

Expected output
| Plan Design | Renewal Dates | Estimated Increase Over 2012 Medical Premium (%) | Estimated Increase Over 2012 Pharmacy Premium (%) | Estimated Increase Over 2012 Total Premium (Medical and Pharmacy) (%) |
|---|---|---|---|---|
| Liberty Network - $50/$75 Copay Non-gated plan | 10/1/2013 – 12/31/2013 | 27.1% | 23.7% | 26.4% |
| All other plans | 10/1/2013 – 12/31/2013 | 23.7% | 23.7% | 23.7% |
Two independent sources of weight in one tablee1
the shaded 2005 columns are bold in every row, and
five whole rows (Net sales, both excluding items affecting comparability rows, Income for the
period, Value creation) are bold across every cell. Each cell is marked from its own glyphs. The
stub heading is italic as well as bold, so it alone among the headings carries <em>.
Source page

Expected output
| Amounts in SEKm, unless otherwise stated | Second quarter 2005 | Second quarter 20041) | Change, % | First half 2005 | First half 20041) | Change, % |
|---|---|---|---|---|---|---|
| Net sales | 33,969 | 31,950 | 6.3 | 63,709 | 62,443 | 2.0 |
| Operating income2) | 1,890 | 1,782 | 6.1 | 3,198 | 2,544 | 25.7 |
| Operating income, excluding items affecting comparability | 1,890 | 2,188 | -13.6 | 3,198 | 3,929 | -18.6 |
| Margin, % | 5.6 | 6.8 | 5.0 | 6.3 | ||
| Income after financial items | 1,695 | 1,738 | -2.5 | 2,906 | 2,422 | 20.0 |
| Income after financial items, excluding items affecting comparability | 1,695 | 2,144 | -20.9 | 2,906 | 3,807 | -23.7 |
| Margin, % | 5.0 | 6.7 | 4.6 | 6.1 | ||
| Income for the period | 1,196 | 1,240 | -3.5 | 2,050 | 1,809 | 13.3 |
| Earnings per share, SEK3) | 4.11 | 4.06 | 1.2 | 7.04 | 5.92 | 18.9 |
| Value creation | 833 | 1,196 | -363 | 1,221 | 2,006 | -785 |
| Return on equity, % | 16.6 | 14.0 | 16.6 | 21.0 |
The same error, seen from both ends
Over-styling comes from reasoning about the category — "this is a header, headers are bold" — instead of from the glyphs. The mirror image is in Barely-Existing Columns and Headers (§9.3.1): a band that is not bold gets missed because a header is expected to be bold.
Both are prevented by the same discipline: detect structure blind to styling, and take styling from the glyphs.
Neighbouring rules, and how they differ
More
Rule id tables-bold-and-italic-inside-tables · tables formatting